this post was submitted on 08 Dec 2023
463 points (99.4% liked)

World News

39019 readers
2189 users here now

A community for discussing events around the World

Rules:

Similarly, if you see posts along these lines, do not engage. Report them, block them, and live a happier life than they do. We see too many slapfights that boil down to "Mom! He's bugging me!" and "I'm not touching you!" Going forward, slapfights will result in removed comments and temp bans to cool off.

We ask that the users report any comment or post that violate the rules, to use critical thinking when reading, posting or commenting. Users that post off-topic spam, advocate violence, have multiple comments or posts removed, weaponize reports or violate the code of conduct will be banned.

All posts and comments will be reviewed on a case-by-case basis. This means that some content that violates the rules may be allowed, while other content that does not violate the rules may be removed. The moderators retain the right to remove any content and ban users.


Lemmy World Partners

News [email protected]

Politics [email protected]

World Politics [email protected]


Recommendations

For Firefox users, there is media bias / propaganda / fact check plugin.

https://addons.mozilla.org/en-US/firefox/addon/media-bias-fact-check/

founded 1 year ago
MODERATORS
 

The Biden Administration on Thursday announced it is setting new policy that will allow it to seize patents for medicines developed with government funding if it believes their prices are too high.

The policy creates a roadmap for the government's so-called march-in rights, which have never been used before. They would allow the government to grant additional licenses to third parties for products developed using federal funds if the original patent holder does not make them available to the public on reasonable terms.

Under the draft roadmap, seen by Reuters, the government will consider factors including whether only a narrow set of patients can afford the drug, and whether drugmakers are exploiting a health or safety issue by hiking prices.

"We'll make it clear that when drug companies won't sell taxpayer funded drugs at reasonable prices, we will be prepared to allow other companies to provide those drugs for less," White House adviser Lael Brainard said on a press call.

you are viewing a single comment's thread
view the rest of the comments
[–] [email protected] 6 points 11 months ago (1 children)

Insulin is a bit complicated. Older formulations of insulin are cheap at this point, but the newer formulations that are more convenient and easy to use are still patented and can be very expensive. There are also newer delivery mechanisms like pens that cost much more than the traditional vial and syringe.

Medical pricing is an insane clusterfuck of imaginary numbers being shuffled around, but total insulin spending in 2022 was around $22 billion. The problem is much deeper than simply needing to raise taxes to throw even more money at the problem (and you're not going to find a simple $22 billion in taxes lying around anyway); you really need to address the core issue of why it's been getting so expensive in the first place, and that's a more complicated issue of corporate greed and regulatory failure. For one issue, it's extremely hard for a manufacturer to become properly licensed to produce insulin, so there's a huge wall any would-be competitors have to climb. Additionally, it is illegal to import it, so Americans are unable to buy insulin from other countries where it's produced much cheaper. Obviously big pharma loves that.

https://diabetes.org/newsroom/press-releases/new-american-diabetes-association-report-finds-annual-costs-diabetes-be

[–] [email protected] 6 points 11 months ago* (last edited 11 months ago)

more convenient and easy to use

Let's be clear, just plain more effective at control. Old insulin allowed type 1 diabetics to become adults before they died young. New formulations let them live full lives. Similarly, insulin resistance in type 2 diabetics will also eventually kill them and only newer types of insulin are effective. It is a matter of life and death.